Home > PJ (current issue) > News / News Centre | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 272 No 7281 p7
3/10 January 2004

This article
Reprint
Photocopy


News summary


Alternative CPR treatment strategy is more effective

Vasopressin followed by adrenaline may be a more effective treatment strategy for refractory cardiac arrest than adrenaline alone, say European researchers. Their finding, published in The New England Journal of Medicine (2004;350:105) has led to a call for a revision of cardiopulmonary resuscitation guidelines.

Researchers from Austria, Germany and Switzerland randomly assigned 1,186 patients who had suffered a cardiac arrest outside

hospital to receive either vasopressin or adrenaline (epinephrine), followed by additional treatment with adrenaline if needed.

They found that among patients with asystole, spontaneous circulation was restored more often in those treated with vasopressin. These patients were also more likely still to be alive at admission to hospital (29.0 per cent of patients given vasopressin survived compared with 20.3 per cent given adrenaline, P=0.02). Furthermore, survival until hospital admission after additional therapy with adrenaline was higher among patients who were initially treated with vasopressin than among those initially treated with adrenaline (25.7 per cent of patients given vasopressin then adrenaline survived compared with 16.4 per cent given adrenaline alone, P=0.002).

In an accompanying editorial (ibid, p179), Kevin McIntyre of Harvard Medical School, Boston says: “This is a remarkable outcome, given that patients in this subgroup could have been deemed to be beyond hope of resuscitation.” Medical policymakers should do whatever is necessary to facilitate the orderly implementation of new guidelines based on this new information, he adds.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal